Cetera Advisors LLC Gilead Sciences, Inc. Transaction History

Cetera Advisors LLC

$0
Q1 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$71.58 - $87.29 $3.71 Million - $4.52 Million	51,801 Added 167.18%	82,786 $6.06 Million
Q4 2023 Feb 13, 2024	BUY	$73.27 - $83.09 $162,659 - $184,459	2,220 Added 7.72%	30,985 $2.51 Million
Q3 2023 Nov 14, 2023	SELL	$73.94 - $80.67 $414,137 - $451,832	-5,601 Reduced 16.3%	28,765 $2.16 Million
Q2 2023 Aug 09, 2023	SELL	$76.01 - $86.7 $153,996 - $175,654	-2,026 Reduced 5.57%	34,366 $2.65 Million
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $756,246 - $861,598	9,782 Added 36.76%	36,392 $3.02 Million
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $570,913 - $819,634	9,161 Added 52.5%	26,610 $2.28 Million
Q3 2022 Nov 10, 2022	BUY	$59.54 - $68.01 $120,151 - $137,244	2,018 Added 13.08%	17,449 $1.08 Million
Q2 2022 Aug 11, 2022	BUY	$57.72 - $65.01 $6,522 - $7,346	113 Added 0.74%	15,431 $954,000
Q1 2022 May 12, 2022	BUY	$57.92 - $72.58 $112,770 - $141,313	1,947 Added 14.56%	15,318 $911,000
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $311,813 - $353,913	-4,806 Reduced 26.44%	13,371 $971,000
Q3 2021 Nov 16, 2021	BUY	$67.69 - $73.03 $268,593 - $289,783	3,968 Added 27.93%	18,177 $1.27 Million
Q2 2021 Aug 13, 2021	BUY	$63.47 - $69.35 $2,157 - $2,357	34 Added 0.24%	14,209 $978,000
Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $181,440 - $207,023	3,024 Added 27.12%	14,175 $916,000
Q4 2020 Feb 17, 2021	SELL	$56.65 - $64.55 $269,200 - $306,741	-4,752 Reduced 29.88%	11,151 $650,000
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $47,506 - $59,731	-765 Reduced 4.59%	15,903 $1.01 Million
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $534,737 - $620,928	-7,392 Reduced 30.72%	16,668 $1.28 Million
Q1 2020 May 08, 2020	BUY	$62.63 - $80.22 $1.02 Million - $1.3 Million	16,242 Added 207.75%	24,060 $1.8 Million
Q4 2019 Feb 10, 2020	SELL	$61.62 - $67.78 $48,125 - $52,936	-781 Reduced 9.08%	7,818 $502,000
Q3 2019 Nov 06, 2019	SELL	$62.51 - $69.0 $227,723 - $251,367	-3,643 Reduced 29.76%	8,599 $549,000
Q2 2019 Aug 12, 2019	SELL	$61.87 - $69.38 $508,447 - $570,164	-8,218 Reduced 40.17%	12,242 $827,000
Q1 2019 May 06, 2019	SELL	$62.53 - $70.05 $21,072 - $23,606	-337 Reduced 1.62%	20,460 $1.35 Million
Q4 2018 Feb 15, 2019	SELL	$60.54 - $79.0 $481,050 - $627,734	-7,946 Reduced 27.64%	20,797 $1.32 Million
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $1.39 Million - $1.54 Million	-19,521 Reduced 40.45%	28,743 $2.23 Million
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $662,814 - $773,146	-10,216 Reduced 17.47%	48,264 $3.42 Million
Q1 2018 May 09, 2018	SELL	$72.84 - $88.8 $147,136 - $179,376	-2,020 Reduced 3.34%	58,480 $4.44 Million
Q4 2017 Feb 08, 2018	SELL	$71.15 - $83.52 $463,755 - $544,383	-6,518 Reduced 9.73%	60,500 $4.34 Million
Q3 2017 Nov 16, 2017	BUY	$72.11 - $85.47 $123,957 - $146,922	1,719 Added 2.63%	67,018 $5.41 Million
Q2 2017 Aug 14, 2017	BUY	N/A	65,299	65,299 $4.62 Million

Others Institutions Holding GILD

# of Institutions

1,931

Shares Held

991M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$10.8 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.4 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$6.88 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.55 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.41 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Advisors LLC with notifications on news.

Account